HomeInsightsPE

Unichem Laboratories Ltd PE Ratio

Unichem Laboratories Ltd PE Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

5.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Unichem Laboratories Ltd

NSE: UNICHEMLAB

PE

120.4

Last updated on: Nov 23, 2024

Key Highlights

  • The P/E Ratio of Unichem Laboratories Ltd is 120.4 as of 23 Nov 14:02 PM .
  • The P/E Ratio of Unichem Laboratories Ltd changed from 63.4 on March 2021 to 0 on March 2024 . This represents a CAGR of -100.00% over 4 years.
  • The Latest Trading Price of Unichem Laboratories Ltd is ₹ 856.1 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Unichem Laboratories Ltd

No data available

Company Fundamentals for Unichem Laboratories Ltd

No data available

Image

Unichem Laboratories Ltd

NSE: UNICHEMLAB

Share Price

₹ 856.1

-4.45 (-0.52%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Unichem Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Unichem Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024856.1
21 Nov 2024860.55
19 Nov 2024881.6
18 Nov 2024878.6
14 Nov 2024894.7
13 Nov 2024876.05
12 Nov 2024876.95
11 Nov 2024884.35
08 Nov 2024900.55
07 Nov 2024896.05

SWOT Analysis Of Unichem Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Unichem Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Unichem Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Unichem Laboratories Ltd1206,027
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Unichem Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Unichem Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Unichem Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Unichem Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Unichem Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Unichem Laboratories Ltd

No data available

* All values are in %

About Unichem Laboratories Ltd

  • Unichem Laboratories Limited is an India-based pharmaceutical company, which manufactures active pharmaceutical ingredients.
  • The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Division and Neu-Foreva Division.
  • The company is headquartered in Mumbai with five manufacturing facilities located at Roha in Maharashtra, Goa, Ghaziabad in Uttar Pradesh, Pithampur in Madhya Pradesh and Baddi in Himachal Pradesh. The company's facilities enjoy credible certifications, the Goa plant was approved by UK MHRA, MCC (South Africa), WHO (Geneva) and TGA (Australia).
  • The Baddi plant was approved by UK MHRA and MCC (South Africa).
  • The company received ISO 9001:2000 for all their plants and corporate office.

Unichem Laboratories Ltd News Hub

News

Board of Unichem Laboratories appoints CFO

The Board of Unichem Laboratories at its meeting held on 08 August 2024 has approved appoi...

Read more

2024-08-08 00:00:00

News

Unichem Laboratories reports consolidated net profit of Rs 9.26 crore in the June 2024 quarter

Net profit of Unichem Laboratories reported to Rs 9.26 crore in the quarter ended June 202...

Read more

2024-08-08 00:00:00

News

Unichem Labs gains on proposal to consolidate USA generics formulations business under one entity

In an exchange filing made before market hours today, the company said that its board will...

Read more

2024-09-23 00:00:00

News

Board of Unichem Laboratories to consider proposal for consolidation of generic formulations biz in US

The Board of Unichem Laboratories will meet on 30 September 2024 to consider and approve i...

Read more

2024-09-23 00:00:00

News

Unichem Laboratories to hold board meeting

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 30 Se...

Read more

2024-09-23 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Unichem Laboratories Ltd

What is the current PE Ratio of Unichem Laboratories Ltd?

The Current PE Ratio of Unichem Laboratories Ltd is 120.41 as on 23 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Nov 2024.

What was the PE Ratio of Unichem Laboratories Ltd last year?

The PE Ratio of Unichem Laboratories Ltd was 0.0 last year, now the PE ratio is 120.41, showing a year-on-year growth of -%.

What does the PE Ratio of Unichem Laboratories Ltd indicate about its stock?

The PE Ratio of Unichem Laboratories Ltd is 120.41. This ratio indicates that investors are willing to pay 120.41 times the earnings per share for each share of Unichem Laboratories Ltd.

What is the PE Ratio Growth of Unichem Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Unichem Laboratories Ltd grew by -% whereas, the EPS ratio grew by 231.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*